Voloridge Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.9M | Buy |
|
|||||
|
2025
Q1 | $92.4M | Buy |
|
|||||
|
2024
Q4 | $108M | Buy |
|
|||||
|
2024
Q3 | $39.8M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $31.6M | Sell |
|
|||||
|
2022
Q3 | $29.8M | Buy |
|
|||||
|
2022
Q2 | $18.7M | Buy |
|
|||||
|
2022
Q1 | $4.36M | Sell |
|
|||||
|
2021
Q4 | $47.9M | Buy |
|
|||||
|
2021
Q3 | $26.8M | Sell |
|
|||||
|
2021
Q2 | $40.6M | Sell |
|
|||||
|
2021
Q1 | $25.2M | Sell |
|
|||||
|
2020
Q4 | $110M | Buy |
|
|||||
|
2020
Q3 | $26.9M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.78M | Sell |
|
|||||
|
2019
Q4 | $3.15M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $426K | Buy |
|